ABSA International
ABSA International

Resources with keywords: covid-19



Healthcare Workers: Information on COVID-19 (Website, Regulatory)
CDC
keywords: covid-19, healthcare
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting (Website, Publication)
New England Journal of Medicine
24 February 2021

A large observational, real-world study from Israel estimates that the Pfizer/BioNTech COVID-19 vaccine is 46% effective at preventing infection 14 to 20 days after the first dose and 92% 7 days after the second dose, backing the results of an earlier randomized, controlled trial.

keywords: covid-19, vaccines
Key Things to Know About COVID-19 Vaccines (Website)
CDC

 Helpful info about the safety of vaccines, how to get a vaccine, the SARS-CoV-2 variants that are causing concern, etc.

keywords: covid-19, vaccines
FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine (Website, Regulatory)
FDA
27 February 2021

 The latest FDA EUA allows the Janssen (J&J) COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.

keywords: covid-19, vaccines
Independent Evaluation of SARS-CoV-2 Antibody Test Performance, FDA Data, 2020-2021 (Website, Regulatory)
CDC
24 February 2021

In collaboration with NCI, CDC, and BARDA, the FDA has developed a comprehensive dataset to compare the performance characteristics of different serological tests that were independently evaluated using well-characterized sample panels of positive and negative specimens for SARS-CoV-2 antibodies. 

Community Transmission of SARS-CoV-2 at Three Fitness Facilities — Hawaii, June–July 2020 (Website, Publication)
CDC/MMWR
24 February 2021

Groves LM, Usagawa L, Elm J, et al.
Twenty-one COVID-19 cases were linked to an index case in a fitness instructor, who, along with a patient who was also an instructor, taught classes <1 day, 1 to <2 days, and ≥2 days before symptom onset; aggregate attack rates were 95%, 13%, and 0%, respectively.

DHS: Master Question List for COVID-19 (caused by SARS-CoV-2) (Document)
DHS
21 February 2021

The DHS Science and Technology Directorate developed the “master question list” that quickly summarizes what is known, what additional information is needed, and who may be working to address such fundamental questions as, “What is the infectious dose?” and “How long does the virus persist in the environment?” This also includes a very comprehensive bibliography.

Laboratory biosafety guidance related to coronavirus disease (COVID-19) (Website, Regulatory)
WHO
1 September 2004

WHO Laboratory Risk Assessment tool is on page 9.

Biosafety Risk Assessment of the Severe Acute Respiratory Syndrome (SARS) Coronavirus and Containment Measures for the Diagnostic and Research Laboratories (Website, Publication)
Applied Biosafety Journal: Journal of ABSA International
1 September 2004

Herman P, Verlinden Y, et al.

COVID-19 Laboratory Workers and Employers (Website, Regulatory)
OSHA

Information on how to classify the risk of laboratory workers based on job tasks

Go to Top